Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol
Primary Endpoint Result Consistent Across All Prespecified Subgroups
Company…Read More
You might also be interested in reading Celebrate Lunar New Year With Exciting Promotions at Shuffle.com.